Why do statins give me muscle pain?

Statins can cause muscle pain in 10-25% of users due to disrupted energy production in muscle cells and reduced CoQ10 levels. The pain ranges from mild aches to severe weakness, but most cases are manageable with dose adjustments, switching medications, or supplementation.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

Understanding Statin-Associated Muscle Symptoms

If you're taking statins and experiencing muscle pain, you're not alone. Studies show that 10-25% of statin users report muscle-related side effects, making it the most common reason people discontinue these cholesterol-lowering medications. This phenomenon, known as statin-associated muscle symptoms (SAMS), can range from mild discomfort to severe pain that interferes with daily activities.

Statins work by blocking HMG-CoA reductase, an enzyme crucial for cholesterol production in the liver. While this effectively lowers LDL cholesterol and reduces cardiovascular risk by 25-35%, the same mechanism can affect muscle cells throughout your body. Understanding why this happens and what you can do about it is essential for maintaining both your heart health and quality of life.

The challenge lies in balancing the proven cardiovascular benefits of statins with their potential side effects. For many people, the muscle pain is manageable or resolves with adjustments, but for others, it becomes a significant barrier to treatment. Regular monitoring of your cholesterol levels and inflammatory markers can help you and your healthcare provider make informed decisions about your treatment plan.

Types of Statin-Associated Muscle Symptoms

CK = Creatine Kinase. Severity increases from myalgia to rhabdomyolysis.
ConditionCK LevelsPrevalenceSymptoms
MyalgiaMyalgiaNormal10-25% of usersMuscle aches, soreness, tenderness without weakness
MyopathyMyopathyNormal to mildly elevated1-5% of usersMuscle weakness with or without pain
MyositisMyositis4-10x upper limit0.1% of usersMuscle pain, weakness, and inflammation
RhabdomyolysisRhabdomyolysis>10x upper limit1-3 per 100,000 patient-yearsSevere pain, weakness, dark urine, kidney risk

CK = Creatine Kinase. Severity increases from myalgia to rhabdomyolysis.

The Science Behind Statin-Induced Muscle Pain

Disrupted Energy Production

The primary mechanism behind statin-induced muscle pain involves the disruption of cellular energy production. Statins interfere with the mevalonate pathway, which produces not only cholesterol but also other important molecules like coenzyme Q10 (CoQ10). This compound is essential for mitochondrial function and energy production in muscle cells.

When CoQ10 levels drop, muscle cells struggle to produce adequate ATP (adenosine triphosphate), the energy currency of cells. This energy deficit can lead to muscle weakness, fatigue, and pain. Research shows that statin users have 16-54% lower muscle CoQ10 levels compared to non-users, with the reduction correlating with symptom severity.

Calcium Regulation Problems

Statins can also affect calcium regulation within muscle cells. They may increase calcium release from the sarcoplasmic reticulum, the muscle cell's calcium storage site, leading to sustained muscle contraction and eventual damage. This disruption in calcium homeostasis can trigger a cascade of events resulting in muscle cell injury and the release of creatine kinase (CK), an enzyme that indicates muscle damage.

Genetic Factors

Your genetic makeup plays a significant role in determining whether you'll experience muscle pain from statins. Variations in the SLCO1B1 gene, which codes for a protein that transports statins into liver cells, can affect how your body processes these medications. People with certain variants of this gene have higher statin concentrations in their blood and muscles, increasing the risk of side effects.

Additionally, variations in genes affecting muscle metabolism, such as those encoding for glycogen phosphorylase and carnitine palmitoyltransferase II, can predispose individuals to statin-induced muscle symptoms. These genetic factors help explain why some people tolerate statins well while others experience significant discomfort at similar doses.

Types and Severity of Muscle Symptoms

Statin-associated muscle symptoms exist on a spectrum, from mild discomfort to potentially life-threatening conditions. Understanding these different presentations can help you communicate effectively with your healthcare provider and recognize when symptoms require immediate attention.

Myalgia: The Most Common Form

Myalgia, or muscle pain without elevated creatine kinase levels, accounts for the majority of statin-related muscle complaints. Patients typically describe the pain as a dull ache, soreness, or tenderness in large muscle groups, particularly the thighs, shoulders, and calves. The discomfort often worsens with exercise and may be accompanied by muscle weakness or fatigue.

Symptoms usually appear within 4-6 weeks of starting statin therapy but can occur at any time during treatment. The pain is typically symmetrical, affecting both sides of the body equally, and may fluctuate in intensity throughout the day.

Myopathy and Myositis

Myopathy represents a more severe form of muscle involvement, characterized by muscle weakness with or without pain. When accompanied by inflammation and elevated CK levels (typically 4-10 times the upper limit of normal), the condition is termed myositis. Patients with myopathy may struggle with activities like climbing stairs, rising from a chair, or lifting objects overhead.

Rhabdomyolysis: A Rare but Serious Complication

Rhabdomyolysis is the most severe form of statin-induced muscle injury, occurring in approximately 1-3 cases per 100,000 patient-years. This condition involves massive muscle breakdown, with CK levels exceeding 10 times the upper limit of normal, often reaching 10,000-100,000 IU/L. Symptoms include severe muscle pain, weakness, dark urine (due to myoglobin release), and potential kidney failure. Immediate medical attention is crucial if these symptoms occur.

Risk Factors for Developing Muscle Pain

Several factors can increase your likelihood of experiencing statin-associated muscle symptoms. Understanding these risk factors can help you and your healthcare provider make informed decisions about statin therapy and monitoring strategies.

  • Age over 65 years, particularly in women
  • Small body frame or low body mass index
  • Kidney or liver disease that affects drug metabolism
  • Hypothyroidism or untreated thyroid disorders
  • Excessive alcohol consumption (more than 2 drinks daily)
  • Intense physical activity or sudden increase in exercise
  • Vitamin D deficiency (levels below 30 ng/mL)
  • Previous history of muscle disorders or unexplained muscle pain
  • Taking multiple medications that interact with statins
  • Asian ancestry (may require lower doses of certain statins)

Drug interactions pose a particularly important risk. Medications that inhibit CYP3A4 enzymes, such as certain antibiotics (clarithromycin, erythromycin), antifungals (ketoconazole, itraconazole), and calcium channel blockers (diltiazem, verapamil), can increase statin blood levels and muscle toxicity risk. Fibrates, another class of lipid-lowering drugs, also increase the risk when combined with statins.

If you have multiple risk factors, your healthcare provider may recommend starting with a lower statin dose, choosing a different statin with fewer drug interactions, or monitoring your muscle enzymes more frequently. Regular testing of your lipid panel, liver enzymes, and thyroid function can help identify and address potential complications early.

Upload your blood test results to track your progress

Seamlessly upload 3rd party biomarker & blood tests to track your whole health in 1 dashboard. Understand what each blood test means and how it fits into the bigger picture of your body and health.

Get diet and lifestyle recommendations based on your blood results, health profile and health goals. You'll also receive a custom supplement recommendation for the precise nutrients your body craves.

Upload Past Blood Test Results

Click or drag file to upload

Once you upload your report, we'll extract the results for your review. Works with top labs including Quest Diagnostics, LabCorp, BioReference, EverlyWell, LetsGetChecked and hundreds of other labs.

Managing and Preventing Statin-Related Muscle Pain

Medication Adjustments

The first approach to managing muscle pain often involves adjusting your statin regimen. Your doctor might reduce the dose, switch to a different statin, or try alternate-day dosing. Hydrophilic statins like pravastatin and rosuvastatin may cause fewer muscle symptoms than lipophilic ones like simvastatin and atorvastatin, as they penetrate muscle tissue less readily.

Some patients benefit from a 'statin holiday' - temporarily discontinuing the medication to see if symptoms resolve, then restarting at a lower dose or with a different statin. This approach helps distinguish true statin-related symptoms from other causes of muscle pain. Studies show that 60-70% of patients who experience muscle symptoms can successfully resume statin therapy with careful rechallenge.

Supplementation Strategies

Several supplements may help reduce statin-associated muscle symptoms. Coenzyme Q10 supplementation (100-200 mg daily) has shown mixed but generally positive results in reducing muscle pain and fatigue. A meta-analysis of randomized controlled trials found that CoQ10 supplementation reduced muscle pain scores by approximately 30% in statin users.

Vitamin D supplementation is particularly important for those with deficiency. Studies suggest that correcting vitamin D levels to above 30 ng/mL can reduce muscle symptoms in up to 90% of deficient patients. Other potentially helpful supplements include magnesium, L-carnitine, and creatine, though evidence for these is less robust.

Lifestyle Modifications

Regular, moderate exercise can actually help reduce statin-related muscle symptoms over time, despite initial discomfort. Start with low-impact activities like walking or swimming, gradually increasing intensity as tolerated. Avoid sudden increases in exercise intensity, which can exacerbate symptoms.

Maintaining proper hydration, getting adequate sleep, and managing stress can also help minimize muscle symptoms. Some patients find that taking their statin at bedtime reduces daytime muscle discomfort, though this varies by individual and statin type.

Alternative Treatment Options

When statin intolerance persists despite management strategies, several alternative approaches can help manage cholesterol and cardiovascular risk. These options vary in effectiveness and may be used alone or in combination.

Non-Statin Medications

Ezetimibe reduces cholesterol absorption in the intestines and can lower LDL cholesterol by 15-20% when used alone. It's often well-tolerated and can be combined with low-dose statins for enhanced effect. PCSK9 inhibitors, injectable medications given every 2-4 weeks, can reduce LDL cholesterol by 50-60% and are particularly useful for patients with familial hypercholesterolemia or statin intolerance.

Bempedoic acid, a newer oral medication, works upstream of statins in the cholesterol synthesis pathway and doesn't appear to cause muscle symptoms. It can lower LDL cholesterol by 15-25% and has shown cardiovascular benefit in clinical trials. Bile acid sequestrants and fibrates offer additional options, though they're generally less effective than statins for LDL reduction.

Natural Approaches

Dietary modifications can significantly impact cholesterol levels. The Portfolio Diet, which emphasizes plant sterols, soluble fiber, soy protein, and nuts, can reduce LDL cholesterol by 20-30% when followed strictly. Red yeast rice, containing naturally occurring statins, may help some patients, though quality and potency vary among products.

Regular physical activity, weight loss, and smoking cessation remain cornerstone interventions for cardiovascular risk reduction, regardless of medication use. These lifestyle changes can improve multiple risk factors simultaneously and may reduce the statin dose needed to achieve target cholesterol levels.

Making Informed Decisions About Your Treatment

Managing statin-associated muscle pain requires a personalized approach that balances cardiovascular benefits with quality of life considerations. While muscle symptoms can be frustrating and uncomfortable, completely discontinuing statin therapy without medical supervision may increase your risk of heart attack or stroke, particularly if you have established cardiovascular disease or multiple risk factors.

Work closely with your healthcare provider to find the right solution for your situation. This might involve trying different statins, adjusting doses, adding supplements, or exploring alternative medications. Keep a symptom diary noting the timing, location, and severity of muscle pain, along with any activities or factors that worsen or improve symptoms.

Remember that the nocebo effect - experiencing side effects due to negative expectations - accounts for a significant portion of reported statin muscle symptoms. Clinical trials using blinded statin/placebo crossovers show that up to 90% of muscle symptoms attributed to statins also occur with placebo. This doesn't mean your symptoms aren't real, but rather highlights the complex relationship between expectations and physical symptoms.

If you're experiencing muscle pain from statins, don't suffer in silence or stop treatment abruptly. With proper evaluation, monitoring, and adjustment of your treatment plan, most people can find a regimen that effectively manages cholesterol while minimizing side effects. Your cardiovascular health is too important to leave to chance, and modern medicine offers multiple pathways to achieve your treatment goals.

For a comprehensive analysis of your existing blood test results and personalized insights into your cholesterol management, consider using SiPhox Health's free upload service. This AI-driven platform can help you understand your biomarkers, track changes over time, and make informed decisions about your cardiovascular health without any lab visits or appointments.

References

  1. Stroes ES, Thompson PD, Corsini A, et al. Statin-associated muscle symptoms: impact on statin therapy-European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management. European Heart Journal. 2015;36(17):1012-1022.[Link][DOI]
  2. Ward NC, Watts GF, Eckel RH. Statin Toxicity: Mechanistic Insights and Clinical Implications. Circulation Research. 2019;124(2):328-350.[Link][DOI]
  3. Rosenson RS, Baker S, Banach M, et al. Optimizing Cholesterol Treatment in Patients With Muscle Complaints. Journal of the American College of Cardiology. 2017;70(10):1290-1301.[Link][DOI]
  4. Qu H, Guo M, Chai H, Wang WT, Gao ZY, Shi DZ. Effects of Coenzyme Q10 on Statin-Induced Myopathy: An Updated Meta-Analysis of Randomized Controlled Trials. Journal of the American Heart Association. 2018;7(19):e009835.[PubMed][DOI]
  5. Newman CB, Preiss D, Tobert JA, et al. Statin Safety and Associated Adverse Events: A Scientific Statement From the American Heart Association. Arteriosclerosis, Thrombosis, and Vascular Biology. 2019;39(2):e38-e81.[Link][DOI]
  6. Michalska-Kasiczak M, Sahebkar A, Mikhailidis DP, et al. Analysis of vitamin D levels in patients with and without statin-associated myalgia - a systematic review and meta-analysis of 7 studies with 2420 patients. International Journal of Cardiology. 2015;178:111-116.[PubMed][DOI]

Was this article helpful?

Frequently Asked Questions

How can I test my cholesterol and muscle enzyme levels at home?

You can monitor your cholesterol and related biomarkers at home with SiPhox Health's Heart & Metabolic Program, which includes comprehensive lipid testing including ApoB, LDL, HDL, and inflammatory markers. This CLIA-certified program provides lab-quality results with personalized insights to help you track your cardiovascular health while managing statin therapy.

What percentage of people experience muscle pain from statins?

Studies show that 10-25% of statin users report muscle-related side effects in real-world settings. However, controlled clinical trials suggest the actual rate directly caused by statins may be lower, around 5-10%, with many symptoms attributed to the nocebo effect or other factors.

Should I stop taking my statin if I experience muscle pain?

Never stop taking statins without consulting your healthcare provider. Abruptly discontinuing can increase cardiovascular risk. Most muscle symptoms can be managed through dose adjustments, switching medications, or adding supplements while maintaining cardiovascular protection.

Can CoQ10 supplements really help with statin muscle pain?

Research on CoQ10 supplementation shows mixed but generally positive results. Meta-analyses suggest that 100-200 mg daily of CoQ10 can reduce muscle pain scores by approximately 30% in some statin users, though individual responses vary.

Are certain statins less likely to cause muscle pain?

Yes, hydrophilic statins like pravastatin and rosuvastatin tend to cause fewer muscle symptoms than lipophilic statins like simvastatin and atorvastatin. This is because hydrophilic statins penetrate muscle tissue less readily.

How long after starting statins do muscle symptoms typically appear?

Muscle symptoms usually appear within 4-6 weeks of starting statin therapy, though they can occur at any time during treatment. Some people experience symptoms immediately, while others develop them after months or years of use.

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details